País: Irlanda
Língua: inglês
Origem: HPRA (Health Products Regulatory Authority)
Gabapentin
Accord Healthcare Ireland Ltd.
N03AX; N03AX12
Gabapentin
600 milligram(s)
Film-coated tablet
Other antiepileptics; gabapentin
Not marketed
2011-12-05
PACKAGE LEAFLET: INFORMATION FOR THE USER GABAPENTIN 600 MG FILM-COATED TABLETS_ _ GABAPENTIN 800 MG FILM-COATED TABLETS_ _ GABAPENTIN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor , pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects,talk to your doctor , pharmacist or nurse.This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Gabapentin Film-coated tablets are and what they are used for 2. What you need to know before you take Gabapentin Film-coated tablets 3. How to take Gabapentin Film-coated tablets 4. Possible side effects 5. How to store Gabapentin Film-coated tablets 6. Content of the pack and other information 1. WHAT GABAPENTIN FILM-COATED TABLETS ARE AND WHAT THEY ARE USED FOR Gabapentin Film-coated tablets belong to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long lasting pain caused by damage to the nerves). The active ingredient in Gabapentin Film-coated tablets is gabapentin. Gabapentin Film-coated tablets are used to treat: • Various forms of epilepsy (seizures that are initially limited to certain parts of the brain, whether the seizure spreads to other parts of the brain or not). The doctor treating you or your child 6 years of age and older will prescribe Gabapentin Film-coated tablets for you to help treat epilepsy when the current treatment is not fully controlling the condition. You or your child 6 years of age and older should take Gabapentin Film-coated tablets in addition to the current treatment unless told otherwise. Gabapentin Film-coated tablets can also be used on its own to treat adults and children over 12 years of age. • Peripheral neuropathic pain Leia o documento completo
Health Products Regulatory Authority 25 July 2023 CRN00DQSD Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gabapentin 600 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg of Gabapentin. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets. Approximately 17.25 mm X 10.15 mm white to off-white, oval shaped, film coated tablets imprinted G1 on one side with black ink and plain on other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Epilepsy Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children aged 6 years and above (see section 5.1). Gabapentin is indicated as monotherapy in the treatment of partial seizures with and without secondary generalization in adults and adolescents aged 12 years and above. Treatment of peripheral neuropathic pain Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For all indications a titration scheme for the initiation of therapy is described in Table 1, which is recommended for adults and adolescents aged 12 years and above. Dosing instructions for children under 12 years of age are provided under a separate sub-heading later in this section. Table 1 DOSING CHART – INITIAL TITRATION Day 1 Day 2 Day 3 300 mg once a day 300 mg two times a day 300 mg three times a day Discontinuation of gabapentin In accordance with current clinical practice, if gabapentin has to be discontinued it is recommended this should be done gradually over a minimum of 1 week independent of the indication. Epilepsy Epilepsy typically requires long-term therapy. Dosage is determined by the treating physician according to individual tolerance and efficacy. _ _ _Adults and adolescents:_ In clinical trials, the effective dosing r Leia o documento completo